Pacira Pharmaceuticals Stock Forecast - Polynomial Regression

PCRX Stock  USD 26.53  0.30  1.12%   
The Polynomial Regression forecasted value of Pacira Pharmaceuticals on the next trading day is expected to be 26.00 with a mean absolute deviation of  0.54  and the sum of the absolute errors of 33.10. Pacira Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Pacira Pharmaceuticals stock prices and determine the direction of Pacira Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Pacira Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Pacira Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Pacira Pharmaceuticals' systematic risk associated with finding meaningful patterns of Pacira Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Pacira Pharmaceuticals to cross-verify your projections.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira Pharmaceuticals guide.
  
At this time, Pacira Pharmaceuticals' Inventory Turnover is fairly stable compared to the past year. Payables Turnover is likely to rise to 16.18 in 2024, whereas Fixed Asset Turnover is likely to drop 1.63 in 2024. . Net Income Applicable To Common Shares is likely to rise to about 19.2 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 35.9 M in 2024.

Open Interest Against 2024-04-19 Pacira Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Pacira Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Pacira Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Pacira Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Pacira Pharmaceuticals' open interest, investors have to compare it to Pacira Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Pacira Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Pacira. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Pacira Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Pacira Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Pacira Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
Pacira Pharmaceuticals polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for Pacira Pharmaceuticals as well as the accuracy indicators are determined from the period prices.

Pacira Pharmaceuticals Polynomial Regression Price Forecast For the 17th of April 2024

Given 90 days horizon, the Polynomial Regression forecasted value of Pacira Pharmaceuticals on the next trading day is expected to be 26.00 with a mean absolute deviation of 0.54, mean absolute percentage error of 0.56, and the sum of the absolute errors of 33.10.
Please note that although there have been many attempts to predict Pacira Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Pacira Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Pacira Pharmaceuticals Stock Forecast Pattern

Backtest Pacira PharmaceuticalsPacira Pharmaceuticals Price PredictionBuy or Sell Advice 

Pacira Pharmaceuticals Forecasted Value

In the context of forecasting Pacira Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Pacira Pharmaceuticals' downside and upside margins for the forecasting period are 23.95 and 28.05, respectively. We have considered Pacira Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
26.53
26.00
Expected Value
28.05
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Pacira Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Pacira Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria117.5265
BiasArithmetic mean of the errors None
MADMean absolute deviation0.5427
MAPEMean absolute percentage error0.0181
SAESum of the absolute errors33.105
A single variable polynomial regression model attempts to put a curve through the Pacira Pharmaceuticals historical price points. Mathematically, assuming the independent variable is X and the dependent variable is Y, this line can be indicated as: Y = a0 + a1*X + a2*X2 + a3*X3 + ... + am*Xm

Predictive Modules for Pacira Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pacira Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pacira Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
24.4826.5428.60
Details
Intrinsic
Valuation
LowRealHigh
23.8834.0836.14
Details
11 Analysts
Consensus
LowTargetHigh
50.1455.1061.16
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.500.630.80
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pacira Pharmaceuticals. Your research has to be compared to or analyzed against Pacira Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Pacira Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Pacira Pharmaceuticals.

Other Forecasting Options for Pacira Pharmaceuticals

For every potential investor in Pacira, whether a beginner or expert, Pacira Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pacira Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pacira. Basic forecasting techniques help filter out the noise by identifying Pacira Pharmaceuticals' price trends.

Pacira Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pacira Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Pacira Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Pacira Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Pacira Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Pacira Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Pacira Pharmaceuticals' current price.

Pacira Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Pacira Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pacira Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Pacira Pharmaceuticals stock market strength indicators, traders can identify Pacira Pharmaceuticals entry and exit signals to maximize returns.

Pacira Pharmaceuticals Risk Indicators

The analysis of Pacira Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pacira Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pacira stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pacira Pharmaceuticals Investors Sentiment

The influence of Pacira Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pacira. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Pacira Pharmaceuticals' public news can be used to forecast risks associated with an investment in Pacira. The trend in average sentiment can be used to explain how an investor holding Pacira can time the market purely based on public headlines and social activities around Pacira Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pacira Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pacira Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Pacira Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Pacira Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pacira Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pacira Pharmaceuticals' short interest history, or implied volatility extrapolated from Pacira Pharmaceuticals options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pacira Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Pacira Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacira Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacira Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacira Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of Pacira Pharmaceuticals to cross-verify your projections.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira Pharmaceuticals guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Pacira Stock analysis

When running Pacira Pharmaceuticals' price analysis, check to measure Pacira Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira Pharmaceuticals is operating at the current time. Most of Pacira Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pacira Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pacira Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Is Pacira Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacira Pharmaceuticals. If investors know Pacira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacira Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.291
Earnings Share
0.89
Revenue Per Share
14.603
Quarterly Revenue Growth
0.054
Return On Assets
0.0335
The market value of Pacira Pharmaceuticals is measured differently than its book value, which is the value of Pacira that is recorded on the company's balance sheet. Investors also form their own opinion of Pacira Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pacira Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacira Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pacira Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacira Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacira Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacira Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.